Skip to content

Impact of Amino Acids to Enhance Anabolism After Home-based Exercise

Impact of Amino Acids to Enhance Anabolism After Home-based Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04850820
Acronym
B2B
Enrollment
12
Registered
2021-04-20
Start date
2021-04-01
Completion date
2021-12-31
Last updated
2022-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amino Acids, Essential, Exercise, Metabolism

Keywords

Home-based resistance exercise, Protein synthesis, Net protein balance, Protein breakdown, Essential amino acids, Branched-chain amino acids, Protein metabolism

Brief summary

An adequate quantity of lean body mass is vital for optimal health and performance, and is accrued when net protein balance (NPB) is positive. Amino acids are the building blocks of protein, and when consumed following resistance exercise, significantly improve NPB. However, no study has investigated how a supplement of all of the essential amino acids (EAA) affects NPB following resistance exercise in a free-living, home-based setting, particularly when compared to a supplement of branched-chain amino acids (BCAA). Therefore, the purpose of this study is to determine the impact of a novel EAA supplement on anabolism (e.g., NPB) as compared to BCAA and placebo supplements following home-based resistance exercise.

Interventions

DIETARY_SUPPLEMENTNovel essential amino acid supplementation

This intervention will determine the impact of EAA+ on markers of whole-body net protein balance, protein synthesis, and protein breakdown following home-based resistance exercise in a free-living setting.

DIETARY_SUPPLEMENTBranched-chain amino acid supplementation (BCAA)

This intervention will determine the impact of the BCAA supplement (to be compared to EAA+) on markers of whole-body net protein balance, protein synthesis, and protein breakdown following home-based resistance exercise in a free-living setting.

DIETARY_SUPPLEMENTIsocaloric carbohydrate supplementation

This intervention will determine the impact of an isocaloric carbohydrate placebo supplement (to be compared to EAA+) on markers of whole-body net protein balance, protein synthesis, and protein breakdown following home-based resistance exercise in a free-living setting.

Sponsors

Iovate Health Sciences International Inc
CollaboratorINDUSTRY
University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

All investigators involved with the study, as well as participants, will be blinded to treatment conditions (double-blind design) until data analysis is completed.

Intervention model description

In a randomized, counterbalanced order, participants will receive all treatments arms (essential amino acids, branched-chain amino acids, and placebo).

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 18-35 years * Recreationally active; currently performing structured exercise (e.g., running, weight lifting, team-sport activity) at least 2 days per week

Exclusion criteria

* Body Mass Index: \>29.9kg/m\^2 * Inability to perform physical activity as determined by the Physical Activity Readiness Questionnaire * Inability to adhere to protocol guidelines (e.g., alcohol, habitual diet) * Regular tobacco use * Illicit drug use (e.g., growth hormone, testosterone) * Diagnosed medical condition under the care of a physician * Inability to abstain from supplements (e.g., protein, creatine, HMB, BCAA, phosphatidic acid) at least three weeks before and during trials * Individuals on any medications known to affect protein metabolism (e.g., corticosteroids, non-steroidal anti-inflammatories, or prescription-strength acne medications)

Design outcomes

Primary

MeasureTime frameDescription
Whole-body net leucine balance (umol/kg)5 hours/trial (four trials total)Used as a proxy of whole-body protein balance, and estimated by using \[13C\]leucine ingestion and breath/urine sample collection

Secondary

MeasureTime frameDescription
Urinary 3-methylhistidine (3-methylhistidine:creatinine ratio)5 hours/trial (four trials total)Used as a marker of muscle protein breakdown by measuring the 3-methylhistidine:creatinine ratio in the urine

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026